Adit Ginde
Concepts (554)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Emergency Service, Hospital | 82 | 2023 | 1815 | 9.080 |
Why?
| Sepsis | 18 | 2023 | 505 | 3.990 |
Why?
| Outpatients | 13 | 2023 | 324 | 3.980 |
Why?
| Critical Illness | 18 | 2023 | 653 | 3.800 |
Why?
| Vitamin D | 19 | 2021 | 339 | 3.180 |
Why?
| Vitamin D Deficiency | 14 | 2021 | 158 | 2.940 |
Why?
| Hospitalization | 40 | 2024 | 1765 | 2.740 |
Why?
| Emergency Medicine | 13 | 2023 | 222 | 2.300 |
Why?
| Cholecalciferol | 6 | 2021 | 47 | 2.290 |
Why?
| Physician Assistants | 7 | 2014 | 65 | 2.270 |
Why?
| Patient Discharge | 11 | 2022 | 770 | 2.270 |
Why?
| Hyperoxia | 4 | 2023 | 97 | 2.270 |
Why?
| Length of Stay | 20 | 2021 | 963 | 2.260 |
Why?
| Adult | 133 | 2024 | 30245 | 2.230 |
Why?
| Humans | 246 | 2024 | 113531 | 2.200 |
Why?
| Hospital Mortality | 17 | 2023 | 780 | 2.130 |
Why?
| Emergency Medical Services | 13 | 2023 | 586 | 2.100 |
Why?
| United States | 85 | 2024 | 12137 | 2.020 |
Why?
| Respiration, Artificial | 10 | 2023 | 536 | 1.970 |
Why?
| Aged | 85 | 2023 | 18944 | 1.910 |
Why?
| Ritonavir | 3 | 2023 | 69 | 1.800 |
Why?
| Middle Aged | 105 | 2024 | 26552 | 1.800 |
Why?
| Wounds and Injuries | 6 | 2022 | 674 | 1.780 |
Why?
| Hospitals | 9 | 2023 | 582 | 1.770 |
Why?
| Patient Transfer | 5 | 2015 | 142 | 1.710 |
Why?
| Respiratory Tract Infections | 7 | 2021 | 320 | 1.680 |
Why?
| Laryngoscopy | 7 | 2023 | 90 | 1.670 |
Why?
| Health Services Accessibility | 11 | 2019 | 756 | 1.640 |
Why?
| Male | 130 | 2023 | 55112 | 1.560 |
Why?
| Influenza, Human | 10 | 2024 | 543 | 1.530 |
Why?
| Oxygen | 8 | 2023 | 827 | 1.490 |
Why?
| Patient Readmission | 5 | 2022 | 608 | 1.470 |
Why?
| Cross-Sectional Studies | 34 | 2023 | 4400 | 1.440 |
Why?
| Female | 127 | 2023 | 59115 | 1.400 |
Why?
| Retrospective Studies | 41 | 2023 | 12504 | 1.270 |
Why?
| Patient Admission | 7 | 2017 | 175 | 1.270 |
Why?
| Nursing Homes | 3 | 2015 | 138 | 1.240 |
Why?
| Laryngoscopes | 6 | 2023 | 38 | 1.230 |
Why?
| Brain Injuries, Traumatic | 2 | 2023 | 295 | 1.220 |
Why?
| Adolescent | 57 | 2024 | 17724 | 1.190 |
Why?
| Aged, 80 and over | 28 | 2021 | 6296 | 1.180 |
Why?
| Influenza Vaccines | 9 | 2024 | 497 | 1.170 |
Why?
| Rural Health Services | 8 | 2020 | 92 | 1.170 |
Why?
| Intensive Care Units | 5 | 2021 | 620 | 1.170 |
Why?
| Vitamins | 7 | 2021 | 150 | 1.160 |
Why?
| Physicians | 10 | 2023 | 765 | 1.150 |
Why?
| Pneumonia | 5 | 2021 | 561 | 1.100 |
Why?
| Medicaid | 4 | 2015 | 404 | 1.100 |
Why?
| Mass Screening | 7 | 2012 | 978 | 1.090 |
Why?
| Health Care Surveys | 17 | 2020 | 541 | 1.070 |
Why?
| Nurse Practitioners | 4 | 2012 | 95 | 1.060 |
Why?
| Antibodies, Neutralizing | 6 | 2022 | 222 | 1.040 |
Why?
| Referral and Consultation | 6 | 2022 | 632 | 1.010 |
Why?
| Young Adult | 38 | 2024 | 10400 | 1.000 |
Why?
| Stroke | 5 | 2022 | 1016 | 0.990 |
Why?
| Rehabilitation Centers | 2 | 2015 | 32 | 0.980 |
Why?
| Intubation, Intratracheal | 10 | 2023 | 216 | 0.960 |
Why?
| Diabetes Mellitus | 6 | 2011 | 896 | 0.940 |
Why?
| Insurance, Health | 5 | 2020 | 243 | 0.920 |
Why?
| Medically Uninsured | 3 | 2014 | 122 | 0.840 |
Why?
| Shock, Traumatic | 1 | 2023 | 15 | 0.840 |
Why?
| Military Personnel | 4 | 2023 | 522 | 0.820 |
Why?
| Internship and Residency | 8 | 2023 | 920 | 0.810 |
Why?
| Minority Groups | 2 | 2023 | 225 | 0.800 |
Why?
| Potentially Inappropriate Medication List | 1 | 2022 | 14 | 0.800 |
Why?
| Antiviral Agents | 6 | 2023 | 635 | 0.790 |
Why?
| Health Services Needs and Demand | 3 | 2013 | 241 | 0.780 |
Why?
| Primary Health Care | 6 | 2019 | 1502 | 0.780 |
Why?
| Treatment Outcome | 24 | 2023 | 9006 | 0.780 |
Why?
| Asthma | 11 | 2012 | 2016 | 0.770 |
Why?
| Airway Management | 1 | 2022 | 59 | 0.770 |
Why?
| Inappropriate Prescribing | 1 | 2022 | 52 | 0.770 |
Why?
| Pneumonia, Viral | 6 | 2020 | 333 | 0.740 |
Why?
| Coronavirus Infections | 6 | 2020 | 325 | 0.740 |
Why?
| Patient Outcome Assessment | 2 | 2021 | 122 | 0.710 |
Why?
| Critical Care | 5 | 2022 | 474 | 0.710 |
Why?
| Substance Abuse Detection | 1 | 2021 | 62 | 0.700 |
Why?
| Career Choice | 3 | 2010 | 177 | 0.690 |
Why?
| Pandemics | 11 | 2023 | 1308 | 0.690 |
Why?
| Antibodies, Monoclonal | 6 | 2022 | 1236 | 0.690 |
Why?
| Age Factors | 12 | 2019 | 2875 | 0.680 |
Why?
| Tracheostomy | 1 | 2021 | 97 | 0.670 |
Why?
| Personnel Selection | 2 | 2010 | 62 | 0.670 |
Why?
| Resuscitation Orders | 2 | 2019 | 45 | 0.660 |
Why?
| Spine | 1 | 2021 | 136 | 0.650 |
Why?
| Translating | 2 | 2010 | 35 | 0.640 |
Why?
| Resuscitation | 1 | 2021 | 221 | 0.630 |
Why?
| Warfare | 1 | 2019 | 74 | 0.630 |
Why?
| Triage | 3 | 2020 | 197 | 0.620 |
Why?
| Conservative Treatment | 1 | 2018 | 29 | 0.610 |
Why?
| Communication Barriers | 2 | 2010 | 88 | 0.610 |
Why?
| Oxygen Inhalation Therapy | 1 | 2019 | 125 | 0.600 |
Why?
| Brain Ischemia | 3 | 2021 | 296 | 0.590 |
Why?
| Prospective Studies | 17 | 2023 | 6189 | 0.590 |
Why?
| Brain Injuries | 1 | 2023 | 449 | 0.590 |
Why?
| Health Surveys | 4 | 2014 | 440 | 0.580 |
Why?
| Obesity | 4 | 2022 | 2501 | 0.580 |
Why?
| Randomized Controlled Trials as Topic | 12 | 2023 | 1205 | 0.570 |
Why?
| Sex Factors | 10 | 2019 | 1705 | 0.570 |
Why?
| Guideline Adherence | 6 | 2022 | 489 | 0.570 |
Why?
| Surgical Procedures, Operative | 2 | 2016 | 208 | 0.550 |
Why?
| Databases, Factual | 10 | 2021 | 1127 | 0.550 |
Why?
| Vaccination | 12 | 2024 | 1198 | 0.550 |
Why?
| Language | 2 | 2010 | 259 | 0.540 |
Why?
| MicroRNAs | 3 | 2017 | 598 | 0.540 |
Why?
| Professional Autonomy | 2 | 2014 | 25 | 0.540 |
Why?
| Interdisciplinary Studies | 1 | 2016 | 26 | 0.540 |
Why?
| Hydroxychloroquine | 3 | 2022 | 54 | 0.540 |
Why?
| Financing, Organized | 1 | 2016 | 33 | 0.540 |
Why?
| Orthopedics | 1 | 2018 | 120 | 0.530 |
Why?
| Healthcare Disparities | 3 | 2012 | 479 | 0.530 |
Why?
| Anti-Infective Agents | 2 | 2022 | 218 | 0.530 |
Why?
| Skilled Nursing Facilities | 2 | 2016 | 119 | 0.530 |
Why?
| Communication | 2 | 2014 | 734 | 0.530 |
Why?
| Home Care Services | 2 | 2016 | 219 | 0.520 |
Why?
| Pilot Projects | 7 | 2023 | 1356 | 0.510 |
Why?
| Acute Disease | 9 | 2020 | 885 | 0.510 |
Why?
| Multiple Trauma | 1 | 2016 | 87 | 0.500 |
Why?
| Severity of Illness Index | 11 | 2022 | 2530 | 0.500 |
Why?
| Boston | 8 | 2010 | 76 | 0.500 |
Why?
| Cross Infection | 2 | 2020 | 195 | 0.490 |
Why?
| Emergencies | 3 | 2015 | 144 | 0.490 |
Why?
| Insurance Coverage | 3 | 2016 | 199 | 0.490 |
Why?
| Catheterization, Central Venous | 1 | 2016 | 83 | 0.490 |
Why?
| Hyperglycemia | 2 | 2009 | 292 | 0.490 |
Why?
| Antibodies, Viral | 4 | 2023 | 519 | 0.490 |
Why?
| Homes for the Aged | 1 | 2015 | 19 | 0.480 |
Why?
| Double-Blind Method | 12 | 2023 | 1643 | 0.480 |
Why?
| Halfway Houses | 1 | 2014 | 2 | 0.470 |
Why?
| Shock, Septic | 4 | 2018 | 185 | 0.460 |
Why?
| Faculty, Medical | 1 | 2016 | 226 | 0.450 |
Why?
| Nutrition Surveys | 6 | 2011 | 225 | 0.450 |
Why?
| Patient Compliance | 3 | 2008 | 523 | 0.450 |
Why?
| Opioid-Related Disorders | 1 | 2021 | 412 | 0.450 |
Why?
| Systemic Inflammatory Response Syndrome | 1 | 2014 | 71 | 0.440 |
Why?
| Analgesics, Opioid | 1 | 2021 | 770 | 0.440 |
Why?
| Risk Factors | 13 | 2021 | 8606 | 0.440 |
Why?
| Dietary Supplements | 6 | 2021 | 459 | 0.440 |
Why?
| Point-of-Care Systems | 3 | 2011 | 130 | 0.430 |
Why?
| Hypoglycemia | 2 | 2008 | 386 | 0.430 |
Why?
| Hospitals, Rural | 2 | 2010 | 31 | 0.430 |
Why?
| Surveys and Questionnaires | 9 | 2017 | 4593 | 0.430 |
Why?
| Betacoronavirus | 3 | 2020 | 246 | 0.430 |
Why?
| Adenosine Monophosphate | 3 | 2021 | 49 | 0.430 |
Why?
| Urban Health Services | 5 | 2020 | 60 | 0.430 |
Why?
| Antibodies, Monoclonal, Humanized | 3 | 2022 | 654 | 0.420 |
Why?
| Alanine | 3 | 2021 | 104 | 0.420 |
Why?
| California | 5 | 2019 | 351 | 0.420 |
Why?
| Medicare | 3 | 2015 | 661 | 0.420 |
Why?
| Inflammatory Bowel Diseases | 1 | 2017 | 283 | 0.410 |
Why?
| International Educational Exchange | 1 | 2012 | 11 | 0.410 |
Why?
| Renal Dialysis | 1 | 2016 | 377 | 0.410 |
Why?
| International Classification of Diseases | 2 | 2014 | 115 | 0.400 |
Why?
| Odds Ratio | 6 | 2018 | 953 | 0.400 |
Why?
| Health Resources | 1 | 2013 | 119 | 0.400 |
Why?
| Tomography, X-Ray Computed | 3 | 2017 | 2269 | 0.400 |
Why?
| Patient Education as Topic | 4 | 2010 | 665 | 0.390 |
Why?
| Treatment Failure | 6 | 2022 | 323 | 0.390 |
Why?
| Oximetry | 2 | 2023 | 80 | 0.390 |
Why?
| Acute Kidney Injury | 3 | 2018 | 676 | 0.390 |
Why?
| Multivariate Analysis | 6 | 2016 | 1421 | 0.390 |
Why?
| Time Factors | 14 | 2023 | 6032 | 0.380 |
Why?
| Logistic Models | 7 | 2021 | 1832 | 0.380 |
Why?
| Hospital Units | 1 | 2011 | 21 | 0.380 |
Why?
| Ambulatory Care | 5 | 2023 | 480 | 0.380 |
Why?
| Observation | 1 | 2011 | 50 | 0.380 |
Why?
| Appointments and Schedules | 1 | 2011 | 70 | 0.380 |
Why?
| Patient Safety | 2 | 2016 | 272 | 0.370 |
Why?
| Inflammation Mediators | 1 | 2014 | 469 | 0.370 |
Why?
| Influenza A Virus, H1N1 Subtype | 2 | 2024 | 137 | 0.370 |
Why?
| Liability, Legal | 1 | 2011 | 38 | 0.370 |
Why?
| Inpatients | 2 | 2021 | 379 | 0.370 |
Why?
| Colorado | 8 | 2023 | 4061 | 0.370 |
Why?
| Hyperparathyroidism, Secondary | 1 | 2011 | 9 | 0.370 |
Why?
| Malpractice | 1 | 2011 | 37 | 0.370 |
Why?
| Blood Glucose | 3 | 2008 | 1823 | 0.370 |
Why?
| Cohort Studies | 13 | 2023 | 4880 | 0.360 |
Why?
| Training Support | 1 | 2010 | 22 | 0.360 |
Why?
| Multicenter Studies as Topic | 5 | 2023 | 248 | 0.360 |
Why?
| Health Care Rationing | 1 | 2010 | 45 | 0.360 |
Why?
| Parathyroid Hormone | 1 | 2011 | 96 | 0.350 |
Why?
| Inflammation | 1 | 2021 | 2444 | 0.350 |
Why?
| Personnel, Hospital | 2 | 2020 | 24 | 0.350 |
Why?
| Military Medicine | 2 | 2022 | 92 | 0.350 |
Why?
| Electronic Health Records | 3 | 2023 | 801 | 0.340 |
Why?
| Digital Rectal Examination | 1 | 2010 | 10 | 0.340 |
Why?
| Risk Assessment | 8 | 2021 | 2953 | 0.340 |
Why?
| Child | 21 | 2022 | 18340 | 0.340 |
Why?
| Occult Blood | 1 | 2010 | 24 | 0.340 |
Why?
| Patient Care | 1 | 2010 | 99 | 0.340 |
Why?
| Ambulances | 3 | 2023 | 48 | 0.330 |
Why?
| Intrauterine Devices | 1 | 2009 | 23 | 0.320 |
Why?
| Body Mass Index | 4 | 2019 | 1952 | 0.320 |
Why?
| Cause of Death | 2 | 2017 | 360 | 0.310 |
Why?
| Influenza A Virus, H3N2 Subtype | 3 | 2024 | 40 | 0.310 |
Why?
| Socioeconomic Factors | 5 | 2015 | 1080 | 0.310 |
Why?
| South Africa | 3 | 2023 | 160 | 0.300 |
Why?
| Atracurium | 2 | 2019 | 13 | 0.300 |
Why?
| Neuromuscular Blocking Agents | 2 | 2019 | 23 | 0.300 |
Why?
| Disease Models, Animal | 1 | 2017 | 3470 | 0.290 |
Why?
| Mathematics | 1 | 2008 | 101 | 0.290 |
Why?
| Health Knowledge, Attitudes, Practice | 3 | 2015 | 1168 | 0.290 |
Why?
| Magnetic Resonance Imaging | 2 | 2008 | 3013 | 0.290 |
Why?
| Pulmonary Disease, Chronic Obstructive | 3 | 2009 | 902 | 0.280 |
Why?
| Age Distribution | 4 | 2014 | 341 | 0.280 |
Why?
| Acute Lung Injury | 2 | 2022 | 266 | 0.270 |
Why?
| Decision Support Systems, Clinical | 2 | 2021 | 176 | 0.270 |
Why?
| Prevalence | 6 | 2014 | 2244 | 0.270 |
Why?
| Community-Acquired Infections | 2 | 2020 | 139 | 0.260 |
Why?
| Ivermectin | 2 | 2023 | 9 | 0.260 |
Why?
| Data Collection | 4 | 2014 | 616 | 0.260 |
Why?
| Cognitive Dysfunction | 2 | 2021 | 285 | 0.260 |
Why?
| Case-Control Studies | 9 | 2022 | 2993 | 0.250 |
Why?
| Emergency Treatment | 3 | 2019 | 113 | 0.250 |
Why?
| Pregnancy Complications | 1 | 2010 | 427 | 0.250 |
Why?
| Staphylococcal Infections | 1 | 2009 | 338 | 0.240 |
Why?
| Child, Preschool | 12 | 2019 | 9093 | 0.240 |
Why?
| Hospitals, Urban | 3 | 2016 | 128 | 0.230 |
Why?
| Disease Progression | 5 | 2021 | 2364 | 0.230 |
Why?
| Vaccines, Synthetic | 5 | 2022 | 124 | 0.230 |
Why?
| Physician-Patient Relations | 1 | 2009 | 459 | 0.230 |
Why?
| Choice Behavior | 2 | 2019 | 148 | 0.230 |
Why?
| Calcitriol | 2 | 2014 | 53 | 0.230 |
Why?
| Fluid Therapy | 2 | 2023 | 123 | 0.230 |
Why?
| Diabetic Ketoacidosis | 1 | 2006 | 161 | 0.230 |
Why?
| Chronic Disease | 3 | 2022 | 1570 | 0.230 |
Why?
| Medical Audit | 2 | 2018 | 75 | 0.230 |
Why?
| Ambulatory Care Facilities | 3 | 2020 | 212 | 0.230 |
Why?
| Seasons | 5 | 2024 | 437 | 0.220 |
Why?
| Patient Acceptance of Health Care | 2 | 2020 | 679 | 0.220 |
Why?
| Attitude of Health Personnel | 1 | 2010 | 970 | 0.220 |
Why?
| Organ Dysfunction Scores | 2 | 2020 | 39 | 0.220 |
Why?
| RNA, Messenger | 7 | 2023 | 2507 | 0.220 |
Why?
| Comorbidity | 4 | 2021 | 1443 | 0.220 |
Why?
| Influenza A virus | 1 | 2024 | 90 | 0.220 |
Why?
| Hypotension | 2 | 2023 | 115 | 0.220 |
Why?
| Receptor, Angiotensin, Type 1 | 1 | 2023 | 19 | 0.210 |
Why?
| Androstadienes | 1 | 2023 | 97 | 0.210 |
Why?
| Immunocompromised Host | 2 | 2022 | 190 | 0.210 |
Why?
| Electronics | 1 | 2023 | 66 | 0.210 |
Why?
| Urinary Tract Infections | 1 | 2004 | 132 | 0.210 |
Why?
| Lopinavir | 1 | 2022 | 29 | 0.210 |
Why?
| Respiratory Syncytial Virus, Human | 1 | 2023 | 60 | 0.210 |
Why?
| Recovery of Function | 3 | 2022 | 567 | 0.210 |
Why?
| Renin-Angiotensin System | 1 | 2023 | 72 | 0.200 |
Why?
| Cytokines | 2 | 2014 | 1795 | 0.200 |
Why?
| Delirium | 1 | 2023 | 67 | 0.200 |
Why?
| Respiratory Syncytial Virus Infections | 1 | 2023 | 97 | 0.200 |
Why?
| Health Services Research | 2 | 2016 | 373 | 0.200 |
Why?
| Biomarkers | 7 | 2021 | 3389 | 0.200 |
Why?
| Syncope | 1 | 2022 | 38 | 0.200 |
Why?
| Incidence | 3 | 2019 | 2310 | 0.190 |
Why?
| Vasoconstrictor Agents | 2 | 2023 | 113 | 0.190 |
Why?
| Rural Population | 3 | 2016 | 441 | 0.190 |
Why?
| Immunization, Secondary | 1 | 2022 | 82 | 0.190 |
Why?
| Veterans Health | 1 | 2023 | 166 | 0.190 |
Why?
| Positive-Pressure Respiration | 2 | 2019 | 67 | 0.190 |
Why?
| Hypoxia | 3 | 2023 | 919 | 0.190 |
Why?
| Polypharmacy | 1 | 2022 | 74 | 0.190 |
Why?
| Academic Medical Centers | 4 | 2020 | 406 | 0.190 |
Why?
| Long Term Adverse Effects | 1 | 2021 | 10 | 0.190 |
Why?
| Malawi | 1 | 2021 | 45 | 0.190 |
Why?
| Drug Prescriptions | 1 | 2003 | 237 | 0.190 |
Why?
| Immunization Programs | 1 | 2023 | 204 | 0.190 |
Why?
| Abdominal Pain | 1 | 2022 | 133 | 0.180 |
Why?
| Vasodilator Agents | 1 | 2023 | 303 | 0.180 |
Why?
| Quality of Health Care | 3 | 2010 | 572 | 0.180 |
Why?
| Bayes Theorem | 1 | 2022 | 325 | 0.180 |
Why?
| Wounds, Penetrating | 1 | 2022 | 67 | 0.180 |
Why?
| Infant | 7 | 2019 | 7922 | 0.180 |
Why?
| Work | 1 | 2020 | 17 | 0.180 |
Why?
| Aftercare | 1 | 2022 | 187 | 0.180 |
Why?
| Contact Tracing | 1 | 2020 | 14 | 0.180 |
Why?
| Telecommunications | 1 | 2020 | 16 | 0.180 |
Why?
| Neuromuscular Blockade | 2 | 2019 | 23 | 0.180 |
Why?
| Video Recording | 4 | 2023 | 141 | 0.170 |
Why?
| Personnel Turnover | 2 | 2010 | 27 | 0.170 |
Why?
| Adrenergic beta-Agonists | 2 | 2012 | 125 | 0.170 |
Why?
| Electrocardiography | 1 | 2003 | 558 | 0.170 |
Why?
| Organ Transplantation | 1 | 2022 | 157 | 0.170 |
Why?
| Physical Therapy Modalities | 1 | 2023 | 265 | 0.170 |
Why?
| Chi-Square Distribution | 3 | 2012 | 493 | 0.170 |
Why?
| Abbreviated Injury Scale | 1 | 2019 | 22 | 0.170 |
Why?
| Respiratory Insufficiency | 1 | 2023 | 285 | 0.170 |
Why?
| Outpatient Clinics, Hospital | 1 | 2020 | 80 | 0.170 |
Why?
| Continuity of Patient Care | 2 | 2012 | 252 | 0.160 |
Why?
| Symptom Assessment | 1 | 2020 | 119 | 0.160 |
Why?
| Adrenal Cortex Hormones | 5 | 2021 | 488 | 0.160 |
Why?
| Iraq | 1 | 2019 | 81 | 0.160 |
Why?
| Dose-Response Relationship, Drug | 3 | 2020 | 1822 | 0.160 |
Why?
| Agkistrodon | 1 | 2019 | 19 | 0.160 |
Why?
| Crotalid Venoms | 1 | 2019 | 31 | 0.160 |
Why?
| Afghanistan | 1 | 2019 | 108 | 0.160 |
Why?
| Immunoglobulin Fab Fragments | 1 | 2019 | 69 | 0.160 |
Why?
| Dantrolene | 1 | 2019 | 5 | 0.160 |
Why?
| Neuromuscular Depolarizing Agents | 1 | 2019 | 4 | 0.160 |
Why?
| Lactic Acid | 1 | 2020 | 269 | 0.160 |
Why?
| Malignant Hyperthermia | 1 | 2019 | 7 | 0.160 |
Why?
| Muscle Relaxants, Central | 1 | 2019 | 9 | 0.160 |
Why?
| Succinylcholine | 1 | 2019 | 6 | 0.160 |
Why?
| Needs Assessment | 3 | 2010 | 314 | 0.160 |
Why?
| Antivenins | 1 | 2019 | 56 | 0.160 |
Why?
| Consensus | 1 | 2021 | 533 | 0.160 |
Why?
| Quality Indicators, Health Care | 2 | 2012 | 285 | 0.160 |
Why?
| Iraq War, 2003-2011 | 1 | 2019 | 151 | 0.160 |
Why?
| Snake Bites | 1 | 2019 | 54 | 0.150 |
Why?
| Injury Severity Score | 2 | 2022 | 468 | 0.150 |
Why?
| Afghan Campaign 2001- | 1 | 2019 | 162 | 0.150 |
Why?
| Platelet-Rich Plasma | 1 | 2018 | 23 | 0.150 |
Why?
| Formative Feedback | 1 | 2018 | 22 | 0.150 |
Why?
| Out-of-Hospital Cardiac Arrest | 1 | 2019 | 78 | 0.150 |
Why?
| Time-to-Treatment | 4 | 2021 | 146 | 0.150 |
Why?
| Clinical Competence | 2 | 2010 | 882 | 0.150 |
Why?
| Cardiovascular Diseases | 1 | 2009 | 1725 | 0.150 |
Why?
| Vaccines | 1 | 2023 | 372 | 0.150 |
Why?
| Survivors | 1 | 2021 | 414 | 0.150 |
Why?
| Biological Specimen Banks | 1 | 2018 | 93 | 0.150 |
Why?
| Hospitals, Teaching | 2 | 2011 | 102 | 0.150 |
Why?
| Cognition | 2 | 2023 | 989 | 0.140 |
Why?
| Specimen Handling | 1 | 2018 | 152 | 0.140 |
Why?
| Certification | 3 | 2020 | 84 | 0.140 |
Why?
| Maryland | 1 | 2017 | 37 | 0.140 |
Why?
| Income | 2 | 2008 | 166 | 0.140 |
Why?
| Oxygen Consumption | 1 | 2019 | 568 | 0.140 |
Why?
| Civil Defense | 1 | 2017 | 18 | 0.140 |
Why?
| Environmental Exposure | 1 | 2020 | 370 | 0.140 |
Why?
| Assisted Living Facilities | 1 | 2016 | 7 | 0.140 |
Why?
| Fibroblast Growth Factors | 1 | 2018 | 161 | 0.140 |
Why?
| Executive Function | 1 | 2021 | 378 | 0.140 |
Why?
| Accidental Falls | 2 | 2016 | 150 | 0.140 |
Why?
| Trachea | 3 | 2023 | 220 | 0.130 |
Why?
| Avalanches | 1 | 2016 | 2 | 0.130 |
Why?
| Educational Status | 2 | 2008 | 404 | 0.130 |
Why?
| Registries | 2 | 2022 | 1762 | 0.130 |
Why?
| Orthopedic Procedures | 1 | 2018 | 206 | 0.130 |
Why?
| Mountaineering | 1 | 2016 | 34 | 0.130 |
Why?
| Predictive Value of Tests | 3 | 2020 | 1783 | 0.130 |
Why?
| Anesthesiology | 1 | 2016 | 35 | 0.130 |
Why?
| Colitis, Ulcerative | 1 | 2017 | 104 | 0.130 |
Why?
| Urban Population | 3 | 2010 | 393 | 0.130 |
Why?
| Advance Directives | 1 | 2016 | 69 | 0.120 |
Why?
| Stress Disorders, Post-Traumatic | 1 | 2023 | 760 | 0.120 |
Why?
| Infant, Newborn | 3 | 2014 | 5032 | 0.120 |
Why?
| AIDS Serodiagnosis | 2 | 2012 | 28 | 0.120 |
Why?
| Efficiency, Organizational | 1 | 2016 | 126 | 0.120 |
Why?
| Precision Medicine | 1 | 2018 | 335 | 0.120 |
Why?
| Pulmonary Embolism | 1 | 2017 | 181 | 0.120 |
Why?
| Evidence-Based Medicine | 2 | 2016 | 662 | 0.120 |
Why?
| Awareness | 1 | 2015 | 93 | 0.120 |
Why?
| Methicillin-Resistant Staphylococcus aureus | 1 | 2017 | 192 | 0.120 |
Why?
| Perioperative Care | 1 | 2016 | 127 | 0.120 |
Why?
| Neoplasms | 1 | 2008 | 2082 | 0.120 |
Why?
| Cost-Benefit Analysis | 1 | 2017 | 542 | 0.110 |
Why?
| Frail Elderly | 1 | 2015 | 106 | 0.110 |
Why?
| Quality Improvement | 1 | 2021 | 951 | 0.110 |
Why?
| Lipopolysaccharides | 1 | 2017 | 802 | 0.110 |
Why?
| Creatinine | 1 | 2015 | 434 | 0.110 |
Why?
| Hepatopulmonary Syndrome | 1 | 2014 | 24 | 0.110 |
Why?
| Health Care Costs | 1 | 2017 | 381 | 0.110 |
Why?
| Crohn Disease | 1 | 2017 | 196 | 0.110 |
Why?
| Confidence Intervals | 3 | 2010 | 302 | 0.110 |
Why?
| Patient-Centered Care | 2 | 2016 | 470 | 0.110 |
Why?
| Fluvoxamine | 2 | 2023 | 12 | 0.110 |
Why?
| Delivery of Health Care | 1 | 2020 | 828 | 0.110 |
Why?
| Risk | 2 | 2017 | 807 | 0.110 |
Why?
| Pneumonia, Bacterial | 1 | 2014 | 102 | 0.110 |
Why?
| Influenza B virus | 2 | 2024 | 34 | 0.100 |
Why?
| Physician's Role | 1 | 2014 | 192 | 0.100 |
Why?
| Vaccines, Combined | 2 | 2022 | 46 | 0.100 |
Why?
| Headache | 1 | 2013 | 127 | 0.100 |
Why?
| Anti-Bacterial Agents | 4 | 2018 | 1465 | 0.100 |
Why?
| Preventive Health Services | 2 | 2012 | 134 | 0.100 |
Why?
| Neutrophils | 1 | 2017 | 1072 | 0.100 |
Why?
| Hospital Costs | 1 | 2013 | 105 | 0.100 |
Why?
| Adaptive Clinical Trials as Topic | 2 | 2022 | 19 | 0.100 |
Why?
| Combined Modality Therapy | 2 | 2019 | 1114 | 0.100 |
Why?
| Immune System | 1 | 2013 | 167 | 0.100 |
Why?
| Sampling Studies | 1 | 2012 | 90 | 0.100 |
Why?
| Oregon | 1 | 2011 | 66 | 0.100 |
Why?
| Epithelial Cells | 1 | 2017 | 939 | 0.100 |
Why?
| Georgia | 1 | 2011 | 62 | 0.100 |
Why?
| Fractures, Bone | 1 | 2016 | 366 | 0.090 |
Why?
| Sex Distribution | 2 | 2013 | 336 | 0.090 |
Why?
| Massachusetts | 1 | 2011 | 134 | 0.090 |
Why?
| Mice, Inbred C57BL | 2 | 2017 | 4617 | 0.090 |
Why?
| HIV | 1 | 2012 | 205 | 0.090 |
Why?
| Drug Administration Schedule | 3 | 2019 | 712 | 0.090 |
Why?
| Mice, Knockout | 1 | 2017 | 2523 | 0.090 |
Why?
| Specialization | 1 | 2011 | 112 | 0.090 |
Why?
| Viral Load | 2 | 2023 | 403 | 0.090 |
Why?
| Professional Practice Location | 1 | 2010 | 26 | 0.090 |
Why?
| Statistics, Nonparametric | 2 | 2009 | 384 | 0.090 |
Why?
| Patient Protection and Affordable Care Act | 1 | 2011 | 99 | 0.090 |
Why?
| Bias | 2 | 2021 | 178 | 0.090 |
Why?
| Health Care Reform | 1 | 2011 | 92 | 0.090 |
Why?
| Workload | 1 | 2011 | 131 | 0.090 |
Why?
| Legislation as Topic | 1 | 2010 | 4 | 0.090 |
Why?
| Delegation, Professional | 1 | 2010 | 1 | 0.090 |
Why?
| Practice Patterns, Physicians' | 1 | 2018 | 1176 | 0.090 |
Why?
| Quality of Life | 1 | 2021 | 2335 | 0.090 |
Why?
| Altitude | 1 | 2014 | 404 | 0.090 |
Why?
| Social Class | 2 | 2009 | 203 | 0.090 |
Why?
| Medical Staff, Hospital | 1 | 2010 | 74 | 0.090 |
Why?
| Medically Underserved Area | 1 | 2010 | 80 | 0.090 |
Why?
| Occupations | 1 | 2010 | 35 | 0.090 |
Why?
| Emergency Nursing | 1 | 2010 | 19 | 0.080 |
Why?
| Sensitivity and Specificity | 1 | 2014 | 1682 | 0.080 |
Why?
| Motivation | 2 | 2012 | 486 | 0.080 |
Why?
| Mental Health Services | 1 | 2014 | 318 | 0.080 |
Why?
| Infusions, Intravenous | 2 | 2023 | 368 | 0.080 |
Why?
| Allied Health Personnel | 1 | 2010 | 43 | 0.080 |
Why?
| Albuterol | 1 | 2010 | 101 | 0.080 |
Why?
| Algorithms | 1 | 2017 | 1462 | 0.080 |
Why?
| Geriatric Assessment | 1 | 2011 | 175 | 0.080 |
Why?
| Medical Order Entry Systems | 1 | 2010 | 41 | 0.080 |
Why?
| Interprofessional Relations | 1 | 2011 | 246 | 0.080 |
Why?
| RNA, Viral | 2 | 2023 | 562 | 0.080 |
Why?
| Population | 1 | 2009 | 27 | 0.080 |
Why?
| Specialty Boards | 1 | 2009 | 32 | 0.080 |
Why?
| Job Satisfaction | 1 | 2010 | 168 | 0.080 |
Why?
| Insulin | 2 | 2009 | 2076 | 0.080 |
Why?
| Self Report | 2 | 2023 | 696 | 0.080 |
Why?
| Forced Expiratory Volume | 1 | 2010 | 468 | 0.080 |
Why?
| Nutritional Status | 1 | 2011 | 286 | 0.080 |
Why?
| Schools, Veterinary | 1 | 2008 | 2 | 0.080 |
Why?
| Disease Management | 2 | 2011 | 554 | 0.080 |
Why?
| Respiratory Syncytial Viruses | 1 | 2008 | 46 | 0.080 |
Why?
| Nurses | 1 | 2010 | 145 | 0.080 |
Why?
| Professional Role | 1 | 2010 | 148 | 0.080 |
Why?
| Fatal Outcome | 1 | 2009 | 280 | 0.080 |
Why?
| Drug Therapy, Combination | 2 | 2021 | 944 | 0.080 |
Why?
| Interleukin-10 | 1 | 2010 | 288 | 0.080 |
Why?
| Smoking Cessation | 1 | 2012 | 373 | 0.080 |
Why?
| Animals | 4 | 2019 | 31162 | 0.080 |
Why?
| Device Removal | 1 | 2009 | 122 | 0.070 |
Why?
| Mexican Americans | 1 | 2009 | 100 | 0.070 |
Why?
| Glucocorticoids | 2 | 2023 | 520 | 0.070 |
Why?
| Immunity, Innate | 2 | 2014 | 716 | 0.070 |
Why?
| Mental Recall | 2 | 2021 | 175 | 0.070 |
Why?
| Statistics as Topic | 1 | 2008 | 287 | 0.070 |
Why?
| Feasibility Studies | 2 | 2023 | 737 | 0.070 |
Why?
| Health Status Indicators | 1 | 2008 | 155 | 0.070 |
Why?
| Morbidity | 1 | 2008 | 275 | 0.070 |
Why?
| Data Interpretation, Statistical | 1 | 2009 | 315 | 0.070 |
Why?
| Glucose Tolerance Test | 1 | 2008 | 338 | 0.070 |
Why?
| Clinical Trials as Topic | 2 | 2022 | 922 | 0.070 |
Why?
| Liver Transplantation | 1 | 2014 | 693 | 0.070 |
Why?
| Forecasting | 1 | 2008 | 329 | 0.070 |
Why?
| RNA | 2 | 2023 | 801 | 0.070 |
Why?
| Administration, Inhalation | 2 | 2023 | 633 | 0.070 |
Why?
| Qualitative Research | 2 | 2022 | 924 | 0.070 |
Why?
| Papillomavirus Vaccines | 1 | 2009 | 221 | 0.070 |
Why?
| Virus Diseases | 1 | 2008 | 192 | 0.070 |
Why?
| Proportional Hazards Models | 1 | 2009 | 1076 | 0.070 |
Why?
| T-Lymphocytes, Regulatory | 1 | 2009 | 337 | 0.060 |
Why?
| Papillomavirus Infections | 1 | 2009 | 258 | 0.060 |
Why?
| Geography | 1 | 2006 | 173 | 0.060 |
Why?
| History, 21st Century | 1 | 2006 | 158 | 0.060 |
Why?
| Staphylococcus aureus | 1 | 2009 | 381 | 0.060 |
Why?
| Self Care | 1 | 2008 | 350 | 0.060 |
Why?
| Calcium | 1 | 2011 | 1086 | 0.060 |
Why?
| History, 20th Century | 1 | 2006 | 265 | 0.060 |
Why?
| Lung | 1 | 2017 | 3497 | 0.060 |
Why?
| Analysis of Variance | 1 | 2008 | 1208 | 0.060 |
Why?
| Postoperative Complications | 1 | 2015 | 2120 | 0.060 |
Why?
| Prognosis | 2 | 2020 | 3318 | 0.060 |
Why?
| Missouri | 1 | 2004 | 61 | 0.060 |
Why?
| Sex Characteristics | 1 | 2008 | 633 | 0.050 |
Why?
| Patient Acuity | 1 | 2023 | 42 | 0.050 |
Why?
| Angiotensins | 1 | 2023 | 10 | 0.050 |
Why?
| Macrolides | 1 | 2003 | 56 | 0.050 |
Why?
| Remission Induction | 1 | 2023 | 233 | 0.050 |
Why?
| Calibration | 1 | 2023 | 125 | 0.050 |
Why?
| Drug Repositioning | 1 | 2022 | 13 | 0.050 |
Why?
| Angiotensin II | 1 | 2023 | 85 | 0.050 |
Why?
| Nucleocapsid | 1 | 2022 | 17 | 0.050 |
Why?
| Emergency Medical Dispatch | 1 | 2022 | 6 | 0.050 |
Why?
| Immunocompetence | 1 | 2022 | 40 | 0.050 |
Why?
| Medical Futility | 1 | 2021 | 20 | 0.050 |
Why?
| Syndrome | 1 | 2022 | 328 | 0.050 |
Why?
| Information Systems | 1 | 2022 | 61 | 0.050 |
Why?
| Health Promotion | 2 | 2022 | 675 | 0.050 |
Why?
| Oligopeptides | 1 | 2023 | 231 | 0.050 |
Why?
| Pulse Therapy, Drug | 1 | 2021 | 6 | 0.050 |
Why?
| HIV Infections | 2 | 2012 | 2440 | 0.050 |
Why?
| Ligands | 1 | 2023 | 553 | 0.050 |
Why?
| Transplant Recipients | 1 | 2022 | 130 | 0.050 |
Why?
| Immunization, Passive | 1 | 2021 | 72 | 0.050 |
Why?
| Antigens, Viral | 1 | 2021 | 174 | 0.050 |
Why?
| Intention to Treat Analysis | 1 | 2020 | 69 | 0.040 |
Why?
| Infectious Disease Transmission, Professional-to-Patient | 1 | 2020 | 5 | 0.040 |
Why?
| Hypoglycemic Agents | 1 | 2008 | 1006 | 0.040 |
Why?
| Immunization | 1 | 2023 | 397 | 0.040 |
Why?
| Personnel Staffing and Scheduling | 2 | 2011 | 79 | 0.040 |
Why?
| Follow-Up Studies | 1 | 2009 | 4384 | 0.040 |
Why?
| Documentation | 1 | 2022 | 166 | 0.040 |
Why?
| Immunization Schedule | 1 | 2022 | 183 | 0.040 |
Why?
| Antimalarials | 1 | 2020 | 24 | 0.040 |
Why?
| Vaccination Coverage | 1 | 2021 | 63 | 0.040 |
Why?
| Health Facilities | 1 | 2021 | 71 | 0.040 |
Why?
| Seroepidemiologic Studies | 1 | 2020 | 137 | 0.040 |
Why?
| Personal Protective Equipment | 1 | 2020 | 50 | 0.040 |
Why?
| Asymptomatic Diseases | 1 | 2020 | 75 | 0.040 |
Why?
| Single-Blind Method | 1 | 2020 | 255 | 0.040 |
Why?
| Recombinant Fusion Proteins | 1 | 2022 | 599 | 0.040 |
Why?
| Practice Guidelines as Topic | 2 | 2022 | 1378 | 0.040 |
Why?
| Education, Medical, Graduate | 1 | 2003 | 366 | 0.040 |
Why?
| ROC Curve | 1 | 2020 | 442 | 0.040 |
Why?
| Ergocalciferols | 1 | 2019 | 11 | 0.040 |
Why?
| Program Evaluation | 1 | 2003 | 821 | 0.040 |
Why?
| Conscious Sedation | 1 | 2019 | 78 | 0.040 |
Why?
| Pregnancy | 1 | 2010 | 5490 | 0.040 |
Why?
| Host-Pathogen Interactions | 1 | 2021 | 295 | 0.040 |
Why?
| Workflow | 1 | 2018 | 132 | 0.040 |
Why?
| Renal Replacement Therapy | 1 | 2018 | 69 | 0.040 |
Why?
| RNA Transport | 1 | 2017 | 23 | 0.040 |
Why?
| Informed Consent | 1 | 2018 | 158 | 0.040 |
Why?
| Controlled Before-After Studies | 1 | 2017 | 13 | 0.040 |
Why?
| Kaplan-Meier Estimate | 1 | 2019 | 809 | 0.040 |
Why?
| Poly(ADP-ribose) Polymerases | 1 | 2017 | 86 | 0.040 |
Why?
| Africa | 1 | 2017 | 92 | 0.030 |
Why?
| Neuropsychological Tests | 1 | 2021 | 924 | 0.030 |
Why?
| Historically Controlled Study | 1 | 2016 | 5 | 0.030 |
Why?
| Gene Knockdown Techniques | 1 | 2017 | 298 | 0.030 |
Why?
| Ghana | 1 | 2015 | 30 | 0.030 |
Why?
| Cell Communication | 1 | 2017 | 274 | 0.030 |
Why?
| Depression | 1 | 2023 | 1131 | 0.030 |
Why?
| Reimbursement, Incentive | 1 | 2015 | 35 | 0.030 |
Why?
| Mortality | 1 | 2017 | 282 | 0.030 |
Why?
| Cathelicidins | 1 | 2014 | 38 | 0.030 |
Why?
| Injections, Intravenous | 1 | 2014 | 195 | 0.030 |
Why?
| Muscle Strength | 1 | 2017 | 270 | 0.030 |
Why?
| Antimicrobial Cationic Peptides | 1 | 2014 | 75 | 0.030 |
Why?
| Nanoparticles | 1 | 2017 | 308 | 0.030 |
Why?
| Clinical Coding | 1 | 2013 | 18 | 0.030 |
Why?
| Internet | 1 | 2017 | 590 | 0.030 |
Why?
| Research Design | 1 | 2018 | 916 | 0.030 |
Why?
| Bed Occupancy | 1 | 2011 | 10 | 0.020 |
Why?
| Domestic Violence | 1 | 2011 | 41 | 0.020 |
Why?
| Longitudinal Studies | 1 | 2017 | 2361 | 0.020 |
Why?
| Resource Allocation | 1 | 2010 | 37 | 0.020 |
Why?
| Salmeterol Xinafoate | 1 | 2010 | 41 | 0.020 |
Why?
| Pamphlets | 1 | 2010 | 22 | 0.020 |
Why?
| Demography | 1 | 2010 | 255 | 0.020 |
Why?
| Tobacco Use Disorder | 1 | 2012 | 230 | 0.020 |
Why?
| Consumer Health Information | 1 | 2010 | 47 | 0.020 |
Why?
| Self Efficacy | 1 | 2012 | 352 | 0.020 |
Why?
| Psychometrics | 1 | 2012 | 608 | 0.020 |
Why?
| Patient Satisfaction | 1 | 2012 | 570 | 0.020 |
Why?
| Teaching | 1 | 2010 | 197 | 0.020 |
Why?
| Research | 1 | 2011 | 387 | 0.020 |
Why?
| Linear Models | 1 | 2009 | 767 | 0.020 |
Why?
| Anti-Asthmatic Agents | 1 | 2010 | 346 | 0.020 |
Why?
| Reproducibility of Results | 1 | 2012 | 2752 | 0.010 |
Why?
|
|
Ginde's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|